Ortenlöf, Niklas
Vallius, Suvi
Karlsson, Helena
Ekström, Claes
Kristiansson, Amanda
Holmqvist, Bo
Göransson, Olga
Vaváková, Magdaléna
Rydén, Martin
Carey, Galen
Barton, Norman
Ley, David
Gram, Magnus
Funding for this research was provided by:
Lund University
Article History
Received: 27 April 2023
Accepted: 27 July 2023
First Online: 15 August 2023
Declarations
:
: Generated Statement: The animal protocols were approved by the Swedish Animal Ethics Committee in Malmö-Lund, Sweden (5.8.18–06020/2019, 5.8.18–11,990/2021 and 5.8.18–12,930/2019)
: Not applicable.
: The authors declare the following potential conflicts of interest concerning the research, authorship, and/or publication of this article: G.C is an employee and shareholder in Takeda Pharmaceutical Company Ltd and N.B was employed by Takeda Pharmaceutical Company Ltd. and is a shareholder of Takeda Pharmaceutical Company Ltd. D.L hold stock/stock options in Premalux AB and has received consulting fees from Shire PLC. All other authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.